Testing effectiveness (Phase 2)Looking for participantsNCT05957367
What this trial is testing
Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Who this might be right for
GIST
Deciphera Pharmaceuticals, LLC 94